These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 24729444

  • 1. Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy.
    Warnke C, von Geldern G, Markwerth P, Dehmel T, Hoepner R, Gold R, Pawlita M, Kümpfel T, Mäurer M, Stangel M, Wegner F, Hohlfeld R, Straeten V, Limmroth V, Weber T, Hermsen D, Kleinschnitz C, Hartung HP, Wattjes MP, Svenningson A, Major E, Olsson T, Kieseier BC, Adams O.
    Ann Neurol; 2014 Dec; 76(6):792-801. PubMed ID: 24729444
    [Abstract] [Full Text] [Related]

  • 2. Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis.
    Wijburg MT, Kleerekooper I, Lissenberg-Witte BI, de Vos M, Warnke C, Uitdehaag BMJ, Barkhof F, Killestein J, Wattjes MP.
    JAMA Neurol; 2018 Jul 01; 75(7):827-833. PubMed ID: 29532061
    [Abstract] [Full Text] [Related]

  • 3. Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy.
    Plavina T, Subramanyam M, Bloomgren G, Richman S, Pace A, Lee S, Schlain B, Campagnolo D, Belachew S, Ticho B.
    Ann Neurol; 2014 Dec 01; 76(6):802-12. PubMed ID: 25273271
    [Abstract] [Full Text] [Related]

  • 4. The effect of plasma exchange on serum anti-JC virus antibodies.
    Subramanyam M, Plavina T, Khatri BO, Fox RJ, Goelz SE.
    Mult Scler; 2013 Jun 01; 19(7):912-9. PubMed ID: 23232602
    [Abstract] [Full Text] [Related]

  • 5. A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
    Lee P, Plavina T, Castro A, Berman M, Jaiswal D, Rivas S, Schlain B, Subramanyam M.
    J Clin Virol; 2013 Jun 01; 57(2):141-6. PubMed ID: 23465394
    [Abstract] [Full Text] [Related]

  • 6. JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab.
    Ryschkewitsch CF, Jensen PN, Monaco MC, Major EO.
    Ann Neurol; 2010 Sep 01; 68(3):384-91. PubMed ID: 20818792
    [Abstract] [Full Text] [Related]

  • 7. Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification.
    Laroni A, Giacomazzi CG, Grimaldi L, Gallo P, Sormani MP, Bertolotto A, McDermott JL, Gandoglia I, Martini I, Vitello G, Rinaldi F, Barzon L, Militello V, Pizzorno M, Bandini F, Capello E, Palù G, Uccelli A, Mancardi GL, Varnier OE.
    J Neuroimmune Pharmacol; 2012 Sep 01; 7(3):665-72. PubMed ID: 22585413
    [Abstract] [Full Text] [Related]

  • 8. JCV detection in multiple sclerosis patients treated with natalizumab.
    Sadiq SA, Puccio LM, Brydon EW.
    J Neurol; 2010 Jun 01; 257(6):954-8. PubMed ID: 20052484
    [Abstract] [Full Text] [Related]

  • 9. Management and outcome of CSF-JC virus PCR-negative PML in a natalizumab-treated patient with MS.
    Kuhle J, Gosert R, Bühler R, Derfuss T, Sutter R, Yaldizli O, Radue EW, Ryschkewitsch C, Major EO, Kappos L, Frank S, Hirsch HH.
    Neurology; 2011 Dec 06; 77(23):2010-6. PubMed ID: 22076540
    [Abstract] [Full Text] [Related]

  • 10. Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab.
    Villar LM, Costa-Frossard L, Masterman T, Fernandez O, Montalban X, Casanova B, Izquierdo G, Coret F, Tumani H, Saiz A, Arroyo R, Fink K, Leyva L, Espejo C, Simó-Castelló M, García-Sánchez MI, Lauda F, Llufriú S, Álvarez-Lafuente R, Olascoaga J, Prada A, Oterino A, de Andrés C, Tintoré M, Ramió-Torrentà L, Rodríguez-Martín E, Picón C, Comabella M, Quintana E, Agüera E, Díaz S, Fernandez-Bolaños R, García-Merino JA, Landete L, Menéndez-González M, Navarro L, Pérez D, Sánchez-López F, Serrano-Castro PJ, Tuñón A, Espiño M, Muriel A, Bar-Or A, Álvarez-Cermeño JC.
    Ann Neurol; 2015 Mar 06; 77(3):447-57. PubMed ID: 25581547
    [Abstract] [Full Text] [Related]

  • 11. Comparison of qPCR with ddPCR for the Quantification of JC Polyomavirus in CSF from Patients with Progressive Multifocal Leukoencephalopathy.
    Ngouth N, Monaco MC, Walker L, Corey S, Ikpeama I, Fahle G, Cortese I, Das S, Jacobson S.
    Viruses; 2022 Jun 08; 14(6):. PubMed ID: 35746716
    [Abstract] [Full Text] [Related]

  • 12. Changes to anti-JCV antibody levels in a Swedish national MS cohort.
    Warnke C, Ramanujam R, Plavina T, Bergström T, Goelz S, Subramanyam M, Kockum I, Rahbar A, Kieseier BC, Holmén C, Olsson T, Hillert J, Fogdell-Hahn A.
    J Neurol Neurosurg Psychiatry; 2013 Nov 08; 84(11):1199-205. PubMed ID: 23463870
    [Abstract] [Full Text] [Related]

  • 13. A case of natalizumab-associated progressive multifocal leukoencephalopathy with repeated negative CSF JCV testing.
    Mazda ME, Brosch JR, Wiens AL, Bonnin JM, Kamer AP, Mattson DH, Snook RJ.
    Int J Neurosci; 2013 May 08; 123(5):353-7. PubMed ID: 23252596
    [Abstract] [Full Text] [Related]

  • 14. Assessment of JC virus DNA in blood and urine from natalizumab-treated patients.
    Rudick RA, O'Connor PW, Polman CH, Goodman AD, Ray SS, Griffith NM, Jurgensen SA, Gorelik L, Forrestal F, Sandrock AW, Goelz SE.
    Ann Neurol; 2010 Sep 08; 68(3):304-10. PubMed ID: 20737514
    [Abstract] [Full Text] [Related]

  • 15. Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies.
    Ho PR, Koendgen H, Campbell N, Haddock B, Richman S, Chang I.
    Lancet Neurol; 2017 Nov 08; 16(11):925-933. PubMed ID: 28969984
    [Abstract] [Full Text] [Related]

  • 16. Improving detection of JC virus by ultrafiltration of cerebrospinal fluid before polymerase chain reaction for the diagnosis of progressive multifocal leukoencephalopathy.
    Nakamichi K, Kawamoto M, Ishii J, Saijo M.
    BMC Neurol; 2019 Oct 25; 19(1):252. PubMed ID: 31653203
    [Abstract] [Full Text] [Related]

  • 17. Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort.
    Trampe AK, Hemmelmann C, Stroet A, Haghikia A, Hellwig K, Wiendl H, Goelz S, Ziegler A, Gold R, Chan A.
    Neurology; 2012 May 29; 78(22):1736-42. PubMed ID: 22592369
    [Abstract] [Full Text] [Related]

  • 18. Anti-JCV antibodies detection and JCV DNA levels in PBMC, serum and urine in a cohort of Spanish Multiple Sclerosis patients treated with natalizumab.
    Dominguez-Mozo MI, Garcia-Montojo M, De Las Heras V, Garcia-Martinez A, Arias-Leal AM, Casanova I, Arroyo R, Alvarez-Lafuente R.
    J Neuroimmune Pharmacol; 2013 Dec 29; 8(5):1277-86. PubMed ID: 23979860
    [Abstract] [Full Text] [Related]

  • 19. Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy.
    Perkins MR, Ryschkewitsch C, Liebner JC, Monaco MC, Himelfarb D, Ireland S, Roque A, Edward HL, Jensen PN, Remington G, Abraham T, Abraham J, Greenberg B, Kaufman C, LaGanke C, Monson NL, Xu X, Frohman E, Major EO, Douek DC.
    PLoS Pathog; 2012 Dec 29; 8(11):e1003014. PubMed ID: 23144619
    [Abstract] [Full Text] [Related]

  • 20. Nearly one-half of Brazilian patients with multiple sclerosis using natalizumab are DNA-JC virus positive.
    Fragoso YD, Mendes MF, Arruda WO, Becker J, Brooks JB, Carvalho Mde J, Comini-Frota ER, Domingues RB, Ferreira ML, Finkelsztejn A, Gama PD, Gomes S, Gonçalves MV, Kaimen-Maciel DR, Morales Rde R, Muniz A, Ruocco HH, Salgado PR, Albuquerque LB, Gama RA, Georgeto S, Lopes J, Oliveira CL, Oliveira FT, Safanelli J, Saldanha PC, Satomi M.
    Arq Neuropsiquiatr; 2013 Oct 29; 71(10):780-2. PubMed ID: 24212514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.